Poly Medicure Share Price in 2022: Chart, Monthly Trends, & Analysis

How did Poly Medicure shares perform in 2022?

Let's find out!

Poly Medicure share price in 2022 was ₹897.85 Its price on 1st January 2022 was ₹958.85, and by 31st December 2022 it moved to ₹897.85, giving a negative return of -6.37% for the year.

Poly Medicure Share Open, High, Low, and Close prices for the Year 2022 are as follows:

Open	High	Low	Close
₹958.85	₹1,045	₹651.1	₹897.85
1st Jan 2022	Occured in Nov 2022	Occured in May 2022	31st Dec 2022

This page will help you understand how Poly Medicure performed in 2022. Let's get started.

For complete insights into Poly Medicure’s incredible stock price performance and growth, see: Poly Medicure Historical Share Price Data from its IPO to 2026

Table: Poly Medicure Share Monthly Close, Low, High Prices for 2022

Month	Poly Medicure	Change%	↑High - ↓Low
Jan	₹901.1	-	↑ ₹994 ↓ ₹818.05
Feb	₹798.4	-11.4%	↑ ₹909.9 ↓ ₹685.6
Mar	₹949.5	18.9%	↑ ₹975 ↓ ₹775.05
Apr	₹872.9	-8.1%	↑ ₹947.95 ↓ ₹862.5
May	₹749.8	-14.2%	↑ ₹914 ↓ ₹651.1
Jun	₹750.85	0.1%	↑ ₹790 ↓ ₹662.4
Jul	₹730.25	-2.8%	↑ ₹790 ↓ ₹719
Aug	₹851.8	16.6%	↑ ₹904 ↓ ₹710
Sep	₹865.2	1.5%	↑ ₹960 ↓ ₹845
Oct	₹921.35	6.4%	↑ ₹1,030 ↓ ₹866.8
Nov	₹977.7	6.1%	↑ ₹1,045 ↓ ₹899
Dec	₹897.85	-8.2%	↑ ₹983 ↓ ₹870

Chart: CandleStick and Line Chart Showing Monthly Prices

[Click on line name to show/hide a line]

What if You invested ₹10,000 in Poly Medicure in 2022?

In 2022, the opening price of Poly Medicure share was ₹958.85. Today, the price stands at ₹1,510.9, reflecting a growth of 57.57%. If we applying the same growth to your investment of ₹10,000 then, your investment of ₹10,000 in 2022 would have become ₹15,757.41 by 2026. This represents a CAGR of 12.04%.

---

You might also like to check: Poly Medicure Stock Price in 2021 or Poly Medicure Stock Price in 2023

---

References: Stock prices on stockpricearchive.com are gathered from reliable sources only. We take prices from stock exchanges only, majorly from BSE and NSE.

Disclaimer: Information is provided ‘as is’ and solely for informational purposes, not for trading purposes or advice.